Relapsed platinum-sensitive Ovarian cancer
Relapsed Platinum-Sensitive Ovarian Cancer
Relapsed platinum-sensitive ovarian cancer is a type of cancer that recurs after treatment with a platinum-based chemotherapy. Approximately 20-30% of patients will experience a recurrence of their ovarian cancer following initial treatment. If the recurrence occurs more than six months after the end of chemotherapy, it is classified as platinum-sensitive which carries a better prognosis than platinum-resistant disease.
Women who experience a relapse of platinum-sensitive ovarian cancer typically lived three times longer than women whose cancer recurred within six months of chemotherapy. It is important to remember that not every relapse is the same, and that treatment options can vary depending on the type and stage of the cancer.
Symptoms of Relapsed Platinum-Sensitive Ovarian Cancer
The most common symptoms of relapsed ovarian cancer are very similar to initial diagnosis and include:
- Abdominal swelling
- Bloating
- Pain in the abdomen or pelvic area
- Changes in bowel habits
- Changes in urine habits
- Unexplained weight loss
- Fatigue
- Loss of appetite
If you experience any of these symptoms, it is important to make an appointment with your doctor as soon as possible.
Treatment of Relapsed Platinum-Sensitive Ovarian Cancer
Relapsed platinum-sensitive ovarian cancer is often treated with a combination of surgery and chemotherapy. Surgery may involve removing the tumor and any diseased tissue or organs. Chemotherapy may include a combination of different drugs, including platinum-based chemotherapy. Other treatments such as targeted therapy or immunotherapy may also be used.
The goal of treatment for relapsed platinum-sensitive ovarian cancer is to prolong life and improve quality of life. It is important to discuss all treatment options with your doctor to determine the best treatment plan for you.
